Alterations in the gut microbiota and the efficacy of adjuvant probiotic therapy in liver cirrhosis

Alterations in the gut microbiota and the efficacy of adjuvant probiotic therapy in liver cirrhosis

BackgroundLiver cirrhosis is the end stage of various chronic liver diseases (CLDs). The gut microbiota can impact the liver environment and trigger chronic liver inflammation through the gut-liver axis. Alteration of the gut microbiota has become an effective strategy in the biological treatment of...

Full description

Bibliographic Details
Main Authors: Zengrong Wu, Hejun Zhou, Deliang Liu, Feihong Deng
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
cirrhosis
gut microbiota
gut-liver axis
short-chain fatty acids
probiotics
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2023.1218552/full

Similar Items

Similar Items